Protease inhibitor implicated

Nature

Volumn 381, Issue 6577, 1996, Pages 26-27

  McNamara, James O ^a   Puranam, Ram S ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN; PROTEINASE INHIBITOR; CYSTATIN B; CYSTEINE PROTEINASE INHIBITOR;

GENE MUTATION; HUMAN; MYOCLONUS EPILEPSY; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; CHROMOSOME 21; GENETICS; MUTATION; PHYSIOLOGY;

CHROMOSOMES, HUMAN, PAIR 21; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; EPILEPSIES, MYOCLONIC; HUMANS; MUTATION;

EID: 0029877612     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/381026a0     Document Type: Short Survey

References (8)

1. Pennacchio, L. A. et al. Science 271, 1731-1734 (1996).
2. Berkovic, S. F., Andermann, F., Carpenter, S & Wolfe, L. S. New Engl. J. Med. 315, 296-305 (1986).
3. Steinlein, O K. et al. Nature Genet. 11, 201-203 (1995).
4. Shoffner, J. M. et al. Cell 61, 931-937 (1990).
5. International Batten Disease Consortium Cell 82, 949-957 (1995).
6. Eldridge, R., Stern, R., Iivanainen, M., Koerber, T. & Wilder, B J. Lancet II, 838-842 (1983).
7. Henskens, Y. M. C., Veerman, E. C. I. & Amerongem, A. V. N. Hoppe-Seyler Z. biol. Chem. 377, 71-86 (1996).
8. Barrett, A J. Ann. N. Y. Acad. Sci. 674, 1-15 (1992).